An ABC investigation finds pharmaceutical companies spent more than $2.6 million on "educational events" for doctors on new-generation blood thinners in just six months in 2015, raising concerns the potentially risky drugs are being prescribed to some patients who may not need them.
No comments:
Post a Comment